Cryotherapy has been established as an ablative modality for the treatment of a wide range of malignancies.
Being minimally invasive, it is associated with less morbidity than conventional extirpative surgical procedures. In recent years, it has been used with success for treating 2 of the common urologic malignancies, that is, prostate and renal cancer. In this review, we highlight the role of cryotherapy as a treatment modality, the proposed destructive mechanisms of action and the risks of its use in the management of prostate and renal malignancy.
Written by:
Mohammed A, Miller S, Douglas-Moore J, Miller M. Are you the author?
Northampton General Hospital, UK.
Reference: Urol Oncol. 2013 Jun 18. pii: S1078-1439(13)00190-7.
doi: 10.1016/j.urolonc.2013.04.004
PubMed Abstract
PMID: 23790537
UroToday.com Prostate Cancer Section
